Ditchcarbon
  • Customers
  1. Organizations
  2. Phastar
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated 5 months ago

Phastar

Company website

Phastar, a leading provider of statistical and data science services, is headquartered in Great Britain and operates across Europe and North America. Founded in 2015, the company has quickly established itself in the pharmaceutical and biotechnology sectors, offering innovative solutions in clinical trial data analysis and reporting. Phastar's core services include advanced statistical programming, data management, and regulatory submissions, distinguished by their commitment to quality and precision. The company has achieved significant milestones, including rapid growth and recognition for its expertise in delivering complex data solutions. With a strong market position, Phastar is known for its collaborative approach and deep understanding of regulatory requirements, making it a trusted partner for clients navigating the complexities of clinical development.

DitchCarbon Score

How does Phastar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Phastar's score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Phastar's reported carbon emissions

Phastar, headquartered in Great Britain, currently does not report any specific carbon emissions data, as no emissions figures are available. The company has not established documented reduction targets or climate pledges, indicating a lack of formal commitments to reduce carbon emissions at this time. Phastar does not inherit emissions data from any parent or related organizations, meaning their climate impact assessment is independent. The absence of specific emissions data and reduction initiatives suggests that Phastar may be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, Phastar may consider aligning with established frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) to enhance their climate commitments in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Phastar's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Phastar is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Phastar is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Curia

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

ADVANZ PHARMA Corp. Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Cambrex Karlskoga

SE
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

ANI Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Supernus Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Prestige Consumer Healthcare Inc

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250731.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy